Prion pathogenesis is unaltered in a mouse strain with a permeable blood-brain barrier

PLoS Pathog. 2018 Nov 29;14(11):e1007424. doi: 10.1371/journal.ppat.1007424. eCollection 2018 Nov.

Abstract

Transmissible spongiform encephalopathies (TSEs) are caused by the prion, which consists essentially of PrPSc, an aggregated, conformationally modified form of the cellular prion protein (PrPC). Although TSEs can be experimentally transmitted by intracerebral inoculation, most instances of infection in the field occur through extracerebral routes. The epidemics of kuru and variant Creutzfeldt-Jakob disease were caused by dietary exposure to prions, and parenteral administration of prion-contaminated hormones has caused hundreds of iatrogenic TSEs. In all these instances, the development of postexposure prophylaxis relies on understanding of how prions propagate from the site of entry to the brain. While much evidence points to lymphoreticular invasion followed by retrograde transfer through peripheral nerves, prions are present in the blood and may conceivably cross the blood-brain barrier directly. Here we have addressed the role of the blood-brain barrier (BBB) in prion disease propagation using Pdgfbret/ret mice which possess a highly permeable BBB. We found that Pdgfbret/ret mice have a similar prion disease incubation time as their littermate controls regardless of the route of prion transmission. These surprising results indicate that BBB permeability is irrelevant to the initiation of prion disease, even when prions are administered parenterally.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Biological Transport
  • Blood-Brain Barrier / metabolism*
  • Brain / blood supply
  • Brain / pathology
  • Cattle
  • Creutzfeldt-Jakob Syndrome / pathology
  • Disease Models, Animal
  • Encephalopathy, Bovine Spongiform / pathology
  • Humans
  • Mice
  • Prion Diseases / metabolism*
  • Prion Diseases / transmission
  • Prion Proteins / metabolism
  • Prions / metabolism*
  • Prions / pathogenicity
  • Scrapie / pathology

Substances

  • Prion Proteins
  • Prions

Grants and funding

AK was supported by Marie-Heim Vögtlin fellowship and the grant 31003A_159154/1 from the Swiss National Science Foundation, and The Swiss Heart Foundation. AA is the recipient of an Advanced Grant of the European Research Council (ERC, No. 250356) and is supported by grants from the GELU foundation, the Swiss National Foundation (SNF, including a Sinergia grant), the Swiss Initiative in Systems Biology, SystemsX.ch (PrionX, SynucleiX), and the Klinische Forschungsschwerpunkte (KFSPs) "small RNAs" and "Human Hemato-Lymphatic Diseases". DH is a recipient of a fellowship from the UZH Grants Office. The funders had no role in study design, data collection and analysis, decision to publish, or preparation of the manuscript.